Integrating Transcriptomics and Machine Learning to Uncover the FLI1-PARP14-Immune Axis in Ulcerative Colitis

Zhizhong Zheng1, Yayu Zhang1, Zhixing Gao1

  • 1Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361102, China.

Genes
|November 27, 2025
PubMed
Summary

This study identified a FLI1-PARP14-immune axis crucial for ulcerative colitis (UC) activity. PARP14 shows promise as a diagnostic biomarker and therapeutic target for this chronic inflammatory bowel disease.